Natasha Hernday

Insider Reports History

Location
Incline Village, NV
Signature
/s/ James Pennington, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Natasha Hernday:

Company Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Director Common Stock 8,731 $223,164 $25.56 11 Jun 2025 Direct
XOMA Royalty Corp Director Common Stock 9,006 $221,637 $24.61 21 May 2025 Direct
Janux Therapeutics, Inc. Director Stock Option (right to buy) 11,667 11 Jun 2025 Direct
ALPINE IMMUNE SCIENCES, INC. Director Stock Option (Right to buy) 0 20 May 2024 Direct

Insider Reports Filed by Natasha Hernday

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JANX Janux Therapeutics, Inc. 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 19:30
XOMA XOMA Royalty Corp 21 May 2025 1 $0 4 Director 23 May 2025, 16:47
JANX Janux Therapeutics, Inc. 19 Jul 2024 2 $0 4/A Director 24 Jul 2024, 20:00
JANX Janux Therapeutics, Inc. 19 Jul 2024 4 $0 4 Director 22 Jul 2024, 20:03
JANX Janux Therapeutics, Inc. 19 Jul 2024 0 $0 3 Director 22 Jul 2024, 20:01
/report/000162619924000100-hernday-natasha-2024-05-20 ALPINE IMMUNE SCIENCES, INC. 20 May 2024 5 $0 4 Director 20 May 2024, 20:13
XOMA XOMA Corp 15 May 2024 2 $0 4 Director 17 May 2024, 16:30
/report/000162619924000013-hernday-natasha-2024-01-02 ALPINE IMMUNE SCIENCES, INC. 02 Jan 2024 1 $0 4 Director 04 Jan 2024, 19:06
XOMA XOMA Corp 17 May 2023 1 $0 4 Director 19 May 2023, 16:30
/report/000162619923000018-hernday-natasha-2023-01-03 ALPINE IMMUNE SCIENCES, INC. 03 Jan 2023 1 $0 4 Director 05 Jan 2023, 17:58
XOMA XOMA Corp 18 May 2022 1 $0 4 Director 20 May 2022, 09:00
/report/000162619922000008-hernday-natasha-2022-01-03 ALPINE IMMUNE SCIENCES, INC. 03 Jan 2022 1 $0 4 Director 04 Jan 2022, 16:24
XOMA XOMA Corp 19 May 2021 1 $0 4 Director 21 May 2021, 16:30